Reinhart Partners’s AbbVie ABBV Stock Holding History

Reinhart Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,980	Closed	-$233K	–	123
2015 Q1	$233K	Buy	3,980 +780	+24%	+$47.1K	0.02%	189
2014 Q4	$209K	Buy	+3,200	New	+$202K	0.02%	179

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Reinhart Partners's ABBV Position: Q2 2015 in Review

Reinhart Partners sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 3,980 shares — an estimated $233K sold.

Reinhart Partners first reported a position in ABBV in Q4 2014 and held it in 2 quarters. The position peaked at $233K in Q1 2015. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Reinhart Partners reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
Reinhart Partners sold 3,980 AbbVie shares in Q2 2015, an estimated $233K.
Reinhart Partners first reported a position in AbbVie in Q4 2014 and held it in 2 quarters.
Reinhart Partners's AbbVie position peaked at $233K in Q1 2015.
1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Reinhart Partners's 13F filing for Q2 2015, filed 7 Jul 2015.